Literature DB >> 12196645

Mortality in patients with dementia after ischemic stroke.

David W Desmond1, Joan T Moroney, Mary Sano, Yaakov Stern.   

Abstract

OBJECTIVE: Although dementia is typically considered to be a consequence of a variety of neurologic diseases, it can also serve as a risk factor for other adverse outcomes. The authors investigated dementia as a predictor of long-term survival among patients with ischemic stroke.
METHODS: Neurologic, neuropsychological, and functional assessments were administered to 453 patients (mean age +/- SD, 72.0 +/- 8.3 years) 3 months after ischemic stroke. The authors diagnosed dementia in 119 (26.3%) of the patients using modified Diagnostic and Statistical Manual of Mental Disorders, Revised 3rd Edition, criteria requiring deficits in memory and two or more additional cognitive domains as well as functional impairment. Dementia as a predictor of long-term survival during up to 10 years of follow-up was then investigated.
RESULTS: The mortality rate was 15.90 deaths per 100 person-years among patients with dementia and 5.37 deaths per 100 person-years among nondemented patients. A Cox proportional hazards analysis found that the relative risk (RR) of death was increased in association with dementia (RR = 2.4; 95% CI = 1.6 to 3.4), adjusting for the following: a major hemispheral stroke syndrome (RR = 1.4); a middle cerebral artery territory index stroke (RR = 1.7); a Stroke Severity Scale score of > or = 4, representing more severe stroke (RR = 1.8); atrial fibrillation (RR = 1.8); congestive heart failure (RR = 2.2); recurrent stroke occurring during follow-up (RR = 3.9); and demographic variables. The risk of death increased in association with the severity of dementia, but it did not differ by dementia subtype.
CONCLUSIONS: Dementia is a significant independent risk factor for reduced survival after ischemic stroke, adjusting for other recognized predictors of mortality. The authors hypothesize that patients with dementia are at an elevated risk of mortality because of their increased burden of cerebrovascular disease, a tendency toward undertreatment for stroke prophylaxis among clinicians, or patient noncompliance with treatment regimens.

Entities:  

Mesh:

Year:  2002        PMID: 12196645     DOI: 10.1212/wnl.59.4.537

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  23 in total

1.  The potential dual effects of anesthetic isoflurane on hypoxia-induced caspase-3 activation and increases in β-site amyloid precursor protein-cleaving enzyme levels.

Authors:  Chuxiong Pan; Zhipeng Xu; Yuanlin Dong; Yiying Zhang; Jun Zhang; Sayre McAuliffe; Yun Yue; Tianzuo Li; Zhongcong Xie
Journal:  Anesth Analg       Date:  2011-04-25       Impact factor: 5.108

2.  Is pre-existing dementia an independent predictor of outcome after stroke? A propensity score-matched analysis.

Authors:  Gustavo Saposnik; Moira K Kapral; Robert Cote; Paula A Rochon; Julie Wang; Stavroula Raptis; Muhammad Mamdani; Sandra E Black
Journal:  J Neurol       Date:  2012-04-25       Impact factor: 4.849

Review 3.  Neuroprotective effect of atypical antipsychotics in cognitive and non-cognitive behavioral impairment in animal models.

Authors:  Jue He; Jiming Kong; Qing-Rong Tan; Xin-Min Li
Journal:  Cell Adh Migr       Date:  2009-01-13       Impact factor: 3.405

4.  How many dementia cases in France and Europe? Alternative projections and scenarios 2010-2050.

Authors:  T Mura; J-F Dartigues; C Berr
Journal:  Eur J Neurol       Date:  2009-10-01       Impact factor: 6.089

Review 5.  Dementia and co-occurring chronic conditions: a systematic literature review to identify what is known and where are the gaps in the evidence?

Authors:  Mark B Snowden; Lesley E Steinman; Lucinda L Bryant; Monique M Cherrier; Kurt J Greenlund; Katherine H Leith; Cari Levy; Rebecca G Logsdon; Catherine Copeland; Mia Vogel; Lynda A Anderson; David C Atkins; Janice F Bell; Annette L Fitzpatrick
Journal:  Int J Geriatr Psychiatry       Date:  2017-02-01       Impact factor: 3.485

6.  Targeting CDK5 post-stroke provides long-term neuroprotection and rescues synaptic plasticity.

Authors:  Johanna A Gutiérrez-Vargas; Herman Moreno; Gloria P Cardona-Gómez
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 7.  Pharmacotherapy for Vascular Cognitive Impairment.

Authors:  Muhammad U Farooq; Jiangyong Min; Christopher Goshgarian; Philip B Gorelick
Journal:  CNS Drugs       Date:  2017-09       Impact factor: 5.749

Review 8.  Poststroke dementia in the elderly.

Authors:  Marie-Anne Mackowiak-Cordoliani; Stéphanie Bombois; Armelle Memin; Hilde Hénon; Florence Pasquier
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

9.  Screening of older community-dwelling people at risk for death and hospitalization: the Assistenza Socio-Sanitaria in Italia project.

Authors:  Giampiero Mazzaglia; Lorenzo Roti; Giacomo Corsini; Angela Colombini; Gavino Maciocco; Niccolò Marchionni; Eva Buiatti; Luigi Ferrucci; Mauro Di Bari
Journal:  J Am Geriatr Soc       Date:  2007-10-18       Impact factor: 5.562

10.  Poststroke Montreal Cognitive Assessment and Recurrent Stroke in Patients With Symptomatic Intracranial Atherosclerosis.

Authors:  Shadi Yaghi; George Cotsonis; Adam de Havenon; Shyam Prahbakaran; Jose G Romano; Ronald M Lazar; Randolph S Marshall; Edward Feldmann; David S Liebeskind
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-02-07       Impact factor: 2.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.